Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Badaoui

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Oncologist|April 29, 2021
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with AbemaciclibSarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, et al.
Translational Lung Cancer Research|April 11, 2022
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapySarah Badaoui, Adel Shahnam, Ross A McKinnon, et al.
The AAPS Journal|January 6, 2021
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine ExposureSarah Badaoui, Ashley M Hopkins, A David Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2022
Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control TrialsAshley M Hopkins, Sarah Badaoui, Ganessan Kichenadasse, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with AtezolizumabEugene Tan, Ahmad Y Abuhelwa, Sarah Badaoui, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2022
A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinomaAhmad Y Abuhelwa, Sarah Badaoui, Hoi-Yee Yuen, et al.
Breast (Edinburgh, Scotland)|April 27, 2021
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclibNatansh D Modi, Ahmad Y Abuhelwa, Sarah Badaoui, et al.
British Journal of Cancer|October 29, 2021
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Oncologist|April 29, 2021
Patient-Reported Outcomes Predict Progression-Free Survival of Patients with Advanced Breast Cancer Treated with AbemaciclibSarah Badaoui, Ganessan Kichenadasse, Andrew Rowland, et al.
Translational Lung Cancer Research|April 11, 2022
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapySarah Badaoui, Adel Shahnam, Ross A McKinnon, et al.
The AAPS Journal|January 6, 2021
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine ExposureSarah Badaoui, Ashley M Hopkins, A David Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2022
Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control TrialsAshley M Hopkins, Sarah Badaoui, Ganessan Kichenadasse, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with AtezolizumabEugene Tan, Ahmad Y Abuhelwa, Sarah Badaoui, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2022
A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinomaAhmad Y Abuhelwa, Sarah Badaoui, Hoi-Yee Yuen, et al.
Breast (Edinburgh, Scotland)|April 27, 2021
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclibNatansh D Modi, Ahmad Y Abuhelwa, Sarah Badaoui, et al.
British Journal of Cancer|October 29, 2021
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, et al.
Pageof 1